Viewing Study NCT00132717



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00132717
Status: COMPLETED
Last Update Posted: 2022-02-16
First Post: 2005-08-02

Brief Title: A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem 0653A-808
Sponsor: Organon and Co
Organization: Organon and Co

Study Overview

Official Title: An Open-Label Multicenter Study to Assess the Efficacy of Switching to a Combination Tablet EzetimibeSimvastatin 10mg40mg Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the effect of an investigational cholesterol-lowering drug in patients who are currently taking an approved medication for hypercholesterolemia high cholesterol levels and have been hospitalized for a heart problem
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2004_046 None None None